Home › Scleroderma › North Carolina › Durham
Scleroderma clinical trials in Durham, NC
7 studies for Scleroderma are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Duke University Medical Center, Durham
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- University of North Carolina TraCS Institute - CTRC, Chapel Hill · 10 mi away
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Duke University Medical Center, Durham
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RecruitingPhase 2/3
- Duke University, Durham
A Study of AZD0120 in Autoimmune Diseases
RecruitingPhase 1
- Research Site, Chapel Hill · 10 mi away
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RecruitingPhase 1
- Duke University, Durham
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecruitingPhase 1
- Duke University Health System, Durham
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY11 studies
- Chicago, IL10 studies
- Ann Arbor, MI10 studies
- Houston, TX9 studies
- Boston, MA7 studies
- Los Angeles, CA7 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- New Orleans, LA6 studies
- Dallas, TX5 studies
- Pittsburgh, PA5 studies
- Plantation, FL4 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)59 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Chronic Lymphocytic Leukemia27 studies
- Ovarian Cancer27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.